The European Journal of Health Economics最新文献_第9页

A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole. 模拟各种费用分摊设计下费用控制激励机制的方法：第一欧元免赔额和甜甜圈洞的应用。

The European Journal of Health Economics Pub Date : 2017-11-01 Epub Date: 2016-11-14 DOI: 10.1007/s10198-016-0843-9

D Cattel, R C van Kleef, R C J A van Vliet

{"title":"A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole.","authors":"D Cattel, R C van Kleef, R C J A van Vliet","doi":"10.1007/s10198-016-0843-9","DOIUrl":"10.1007/s10198-016-0843-9","url":null,"abstract":"Many health insurance schemes include deductibles to provide consumers with cost containment incentives (CCI) and to counteract moral hazard. Policymakers are faced with choices on the implementation of a specific cost sharing design. One of the guiding principles in this decision process could be which design leads to the strongest CCI. Despite the vast amount of literature on the effects of cost sharing, the relative effects of specific cost sharing designs-e.g., a traditional deductible versus a doughnut hole-will mostly be absent for a certain context. This papers aims at developing a simulation model to approximate the relative effects of different deductible modalities on the CCI. We argue that the CCI depends on the probability that healthcare expenses end up in the deductible range and the expected healthcare expenses given that they end up in the deductible range. Our empirical application shows that different deductible modalities result in different CCIs and that the CCI under a certain modality differs across risk-groups.","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81935707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Costs of dementia in the Czech Republic 捷克共和国痴呆症的费用

The European Journal of Health Economics Pub Date : 2017-11-01 DOI: 10.1007/s10198-016-0842-x

I. Holmerová, J. Hort, R. Rusina, A. Wimo, M. Šteffl

引用次数: 22

Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth 早产的成本效应:出生后3年内与早期早产、晚期早产和足月分娩相关的卫生保健费用的比较

The European Journal of Health Economics Pub Date : 2017-11-01 DOI: 10.1007/s10198-016-0850-x

J. Jacob, M. Lehne, A. Mischker, N. Klinger, Claudia Zickermann, J. Walker

引用次数: 37

Measuring customer preferences in the German statutory health insurance 衡量顾客对德国法定健康保险的偏好

The European Journal of Health Economics Pub Date : 2017-09-01 DOI: 10.1007/s10198-016-0829-7

Jonas B. Pendzialek, Dusan Simic, S. Stock

引用次数: 6

On vaccination programs in the EU Member States: the case of the human papilloma virus 关于欧盟成员国的疫苗接种计划:人类乳头状瘤病毒的案例

The European Journal of Health Economics Pub Date : 2017-09-01 DOI: 10.1007/s10198-016-0860-8

Reyes Lorente, F. Antoñanzas

引用次数: 0

The social cost of drugs in France in 2010 2010年法国药品的社会成本

The European Journal of Health Economics Pub Date : 2017-09-01 DOI: 10.1007/s10198-016-0835-9

P. Kopp, Marysia Ogrodnik

引用次数: 12

The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. 在瑞典初级保健和社区预防项目中，针对生活方式改变预防糖尿病的干预措施的成本效益。

The European Journal of Health Economics Pub Date : 2017-09-01 Epub Date: 2016-12-02 DOI: 10.1007/s10198-016-0851-9

Anne Neumann, Lars Lindholm, Margareta Norberg, Olaf Schoffer, Stefanie J Klug, Fredrik Norström

{"title":"The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.","authors":"Anne Neumann, Lars Lindholm, Margareta Norberg, Olaf Schoffer, Stefanie J Klug, Fredrik Norström","doi":"10.1007/s10198-016-0851-9","DOIUrl":"10.1007/s10198-016-0851-9","url":null,"abstract":"Background: Policymakers need to know the cost-effectiveness of interventions to prevent type 2 diabetes (T2D). The objective of this study was to estimate the cost-effectiveness of a T2D prevention initiative targeting weight reduction, increased physical activity and healthier diet in persons in pre-diabetic states by comparing a hypothetical intervention versus no intervention in a Swedish setting.Methods: A Markov model was used to study the cost-effectiveness of a T2D prevention program based on lifestyle change versus a control group where no prevention was applied. Analyses were done deterministically and probabilistically based on Monte Carlo simulation for six different scenarios defined by sex and age groups (30, 50, 70 years). Cost and quality adjusted life year (QALY) differences between no intervention and intervention and incremental cost-effectiveness ratios (ICERs) were estimated and visualized in cost-effectiveness planes (CE planes) and cost-effectiveness acceptability curves (CEA curves).Results: All ICERs were cost-effective and ranged from 3833 €/QALY gained (women, 30 years) to 9215 €/QALY gained (men, 70 years). The CEA curves showed that the probability of the intervention being cost-effective at the threshold value of 50,000 € per QALY gained was very high for all scenarios ranging from 85.0 to 91.1%.Discussion/conclusion: The prevention or the delay of the onset of T2D is feasible and cost-effective. A small investment in healthy lifestyle with change in physical activity and diet together with weight loss are very likely to be cost-effective.","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10198-016-0851-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83271896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 30

The social cost of chronic kidney disease in Italy. 意大利慢性肾病的社会成本。

The European Journal of Health Economics Pub Date : 2017-09-01 Epub Date: 2016-10-03 DOI: 10.1007/s10198-016-0830-1

Giuseppe Turchetti, S Bellelli, M Amato, S Bianchi, P Conti, A Cupisti, V Panichi, A Rosati, F Pizzarelli

{"title":"The social cost of chronic kidney disease in Italy.","authors":"Giuseppe Turchetti, S Bellelli, M Amato, S Bianchi, P Conti, A Cupisti, V Panichi, A Rosati, F Pizzarelli","doi":"10.1007/s10198-016-0830-1","DOIUrl":"10.1007/s10198-016-0830-1","url":null,"abstract":"This study aims to estimate the mean annual social cost per patient with chronic kidney disease (CKD) by stages 4 and 5 pre-dialyses and cost components in Italy. The multicenter cross-sectional study included all adult outpatients in charge of the 14 main Nephrology Centers of Tuscany Region during 7 weeks from 2012 to 2013. Direct medical costs have been estimated using tariffs for laboratory tests, diagnostic exams, visits, hospitalization and prices for drugs. Non-medical costs included expenses of low-protein special foods, travel, and formal and informal care. Patients' and caregivers' losses of productivity have been estimated as indirect costs using the human capital approach. Costs have been expressed in Euros (2016). Totals of 279 patients in stage 4 and 205 patients in stage 5 have been enrolled. The estimated mean annual social cost of a patient with CKD were €7422 (±€6255) for stage 4 and €8971 (±€6503) for stage 5 (p < 0.05). Direct medical costs were higher in stage 5 as compared to stage 4; direct non-medical costs and indirect costs accounted, respectively, for 41 and 5 % of the total social cost of CKD stage 4 and for 33 and 9 % of CKD stage 5. In Italy, the overall annual social cost of CKD was €1,809,552,398 representing 0.11 % of the Gross Domestic Product. Direct non-medical costs and indirect costs were weighted on the social cost of CKD almost as much as the direct medical cost. Patients, their families and the productivity system sustain the burden of the disease almost as much as the healthcare system.","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84497043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Healthier lifestyles after retirement in Europe? Evidence from SHARE 退休后在欧洲的生活方式更健康?来自SHARE的证据

The European Journal of Health Economics Pub Date : 2017-09-01 DOI: 10.1007/s10198-016-0828-8

M. Celidoni, Vincenzo Rebba

引用次数: 56

Age effects in mortality risk valuation 年龄对死亡率风险评估的影响

The European Journal of Health Economics Pub Date : 2017-09-01 DOI: 10.1007/s10198-016-0852-8

Raul Brey, J. Pinto-Prades

引用次数: 3